About
Contact & Profiles
Research Areas
- Porphyrin Metabolism and Disorders
- CRISPR and Genetic Engineering
- Genetic and Kidney Cyst Diseases
- Biomedical Research and Pathophysiology
- Virus-based gene therapy research
Universidad de Navarra
2024
The therapeutic use of adeno-associated viral vector (AAV)-mediated gene disruption using CRISPR-Cas9 is limited by potential off-target modifications and the risk uncontrolled integration genomes into CRISPR-mediated double-strand breaks. To address these concerns, we explored AAV-delivered paired Staphylococcus aureus nickases (D10ASaCas9) to target Hao1 for treatment primary hyperoxaluria type 1 (PH1). Our study demonstrated effective disruption, a significant decrease in glycolate...
10.1038/s44321-023-00008-8
article
EN
cc-by
EMBO Molecular Medicine
2024-01-05
10.1016/s0168-8278(24)01975-5
article
EN
Journal of Hepatology
2024-06-01
Coming Soon ...